OPKO Health, Inc. Investing Cash Flow
OPKO Health, Inc. (OPK) reported Investing Cash Flow of $13.74 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-28
- OPKO Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $15.54M.
- OPKO Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$1.80M, a 104.44% decline year-over-year.
- OPKO Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.05M, a 101.76% decline year-over-year.
- OPKO Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $194.65M, a 21.44% decline year-over-year.
- OPKO Health, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $230.30M, a 34.61% decline from fiscal 2024.
- OPKO Health, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $352.21M.
- OPKO Health, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$18.20M, a 119.99% decline from fiscal 2022.
- OPKO Health, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $91.04M, a 153.24% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.54M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $13.74M 10-Q/A · filed 2026-08-28 | $11.69M derived: sum of 3 quarters · filed 2026-08-28 | $206.34M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | -$1.80M 10-Q/A · filed 2026-08-28 | -$3.85M derived: sum of 2 quarters · filed 2026-08-28 | $190.80M derived: sum of 3 quarters · filed 2026-08-28 | $187.97M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $192.60M derived: sum of 2 quarters · filed 2026-02-26 | $189.77M derived: sum of 3 quarters · filed 2026-08-28 | $230.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $194.65M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $191.81M derived: sum of 2 quarters · filed 2026-08-28 | $232.34M 10-Q · filed 2025-10-29 | $348.33M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | -$2.83M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $37.69M 10-Q/A · filed 2026-08-28 | $153.68M derived: sum of 3 quarters · filed 2026-08-28 | $401.46M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $40.53M 10-Q/A · filed 2026-08-28 | $156.51M derived: sum of 2 quarters · filed 2026-08-28 | $404.30M derived: sum of 3 quarters · filed 2026-08-28 | $397.14M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $115.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $363.77M derived: sum of 2 quarters · filed 2026-02-26 | $356.61M derived: sum of 3 quarters · filed 2026-02-26 | $352.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | $247.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $240.62M derived: sum of 2 quarters · filed 2025-10-29 | $236.23M 10-Q · filed 2025-10-29 | $234.81M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$7.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$11.56M 10-Q · filed 2025-07-31 | -$12.97M derived: sum of 3 quarters · filed 2026-02-26 | -$16.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$4.39M 10-Q · filed 2025-05-01 | -$5.81M derived: sum of 2 quarters · filed 2026-02-26 | -$9.38M derived: sum of 3 quarters · filed 2026-02-26 | -$14.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.99M derived: sum of 2 quarters · filed 2026-02-26 | -$10.48M derived: sum of 3 quarters · filed 2026-02-26 | -$18.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$9.06M derived: sum of 2 quarters · filed 2024-11-07 | -$16.78M 10-Q · filed 2024-11-07 | -$24.65M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$13.21M 10-Q · filed 2024-08-07 | -$21.08M derived: sum of 3 quarters · filed 2025-03-03 | -$25.76M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$7.72M 10-Q · filed 2024-05-07 | -$15.59M derived: sum of 2 quarters · filed 2025-03-03 | -$20.27M derived: sum of 3 quarters · filed 2025-03-03 | $88.22M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$12.55M derived: sum of 2 quarters · filed 2025-03-03 | $95.94M derived: sum of 3 quarters · filed 2025-03-03 | $91.04M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$4.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $103.81M derived: sum of 2 quarters · filed 2023-11-06 | $98.91M 10-Q · filed 2023-11-06 | $90.23M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $108.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $103.59M 10-Q · filed 2023-08-03 | $94.91M derived: sum of 3 quarters · filed 2024-03-01 | $149.49M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | -$4.90M 10-Q · filed 2023-05-03 | -$13.58M derived: sum of 2 quarters · filed 2024-03-01 | $40.99M derived: sum of 3 quarters · filed 2024-03-01 | $32.15M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | -$8.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $45.90M derived: sum of 2 quarters · filed 2024-03-01 | $37.05M derived: sum of 3 quarters · filed 2024-03-01 | $35.95M 10-K · filed 2024-03-01 |
| 2021-09-30 | $54.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $45.73M derived: sum of 2 quarters · filed 2022-11-08 | $44.63M 10-Q · filed 2022-11-08 | $37.88M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$8.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$9.95M 10-Q · filed 2022-08-04 | -$16.69M derived: sum of 3 quarters · filed 2023-02-27 | -$11.19M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$1.11M 10-Q · filed 2022-05-09 | -$7.85M derived: sum of 2 quarters · filed 2023-02-27 | -$2.35M derived: sum of 3 quarters · filed 2023-02-27 | -$13.81M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.24M derived: sum of 2 quarters · filed 2023-02-27 | -$12.71M derived: sum of 3 quarters · filed 2023-02-27 | -$18.33M 10-K · filed 2023-02-27 |
| 2020-09-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$5.96M derived: sum of 2 quarters · filed 2021-10-28 | -$11.58M 10-Q · filed 2021-10-28 | -$15.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$11.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$17.08M 10-Q · filed 2021-07-29 | -$20.84M derived: sum of 3 quarters · filed 2022-03-01 | -$23.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$5.62M 10-Q · filed 2021-04-28 | -$9.38M derived: sum of 2 quarters · filed 2022-03-01 | -$11.57M derived: sum of 3 quarters · filed 2022-03-01 | -$14.76M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$5.95M derived: sum of 2 quarters · filed 2022-03-01 | -$9.14M derived: sum of 3 quarters · filed 2022-03-01 | -$13.27M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$5.38M derived: sum of 2 quarters · filed 2020-10-29 | -$9.51M 10-Q · filed 2020-10-29 | -$12.40M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | -$3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$7.32M 10-Q · filed 2020-07-31 | -$10.21M derived: sum of 3 quarters · filed 2021-02-18 | -$21.78M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | -$4.13M 10-Q · filed 2020-05-06 | -$7.01M derived: sum of 2 quarters · filed 2021-02-18 | -$18.59M derived: sum of 3 quarters · filed 2021-02-18 | -$25.11M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$14.45M derived: sum of 2 quarters · filed 2021-02-18 | -$20.97M derived: sum of 3 quarters · filed 2021-02-18 | -$26.12M 10-K · filed 2021-02-18 |
| 2018-09-30 | -$11.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$18.09M derived: sum of 2 quarters · filed 2019-11-05 | -$23.24M 10-Q · filed 2019-11-05 | -$37.19M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$11.67M 10-Q · filed 2019-08-07 | -$25.62M derived: sum of 3 quarters · filed 2020-03-02 | -$41.92M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$5.15M 10-Q · filed 2019-05-08 | -$19.10M derived: sum of 2 quarters · filed 2020-03-02 | -$35.40M derived: sum of 3 quarters · filed 2020-03-02 | -$45.37M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$13.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$30.25M derived: sum of 2 quarters · filed 2020-03-02 | -$40.23M derived: sum of 3 quarters · filed 2020-03-02 | -$46.67M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$26.27M derived: sum of 2 quarters · filed 2018-11-09 | -$32.71M 10-Q · filed 2018-11-09 | -$39.19M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$9.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$16.41M 10-Q · filed 2018-08-07 | -$22.89M derived: sum of 3 quarters · filed 2019-03-01 | -$3.40M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$6.44M 10-Q · filed 2018-05-08 | -$12.92M derived: sum of 2 quarters · filed 2019-03-01 | $6.57M derived: sum of 3 quarters · filed 2019-03-01 | -$17.08M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $13.01M derived: sum of 2 quarters · filed 2019-03-01 | -$10.64M derived: sum of 3 quarters · filed 2019-03-01 | -$20.70M 10-K · filed 2019-03-01 |
| 2016-09-30 | $19.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$4.16M derived: sum of 2 quarters · filed 2017-11-08 | -$14.22M 10-Q · filed 2017-11-08 | -$22.16M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | -$23.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$33.71M 10-Q · filed 2017-08-08 | -$41.65M derived: sum of 3 quarters · filed 2019-01-29 | -$34.47M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | -$10.06M 10-Q · filed 2017-05-10 | -$18.00M derived: sum of 2 quarters · filed 2019-01-29 | -$10.82M derived: sum of 3 quarters · filed 2019-01-29 | -$108.92M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | -$7.94M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | -$763.00K derived: sum of 2 quarters · filed 2019-01-29 | -$98.86M derived: sum of 3 quarters · filed 2019-01-29 | -$99.22M 8-K · filed 2019-01-29 |
| 2015-09-30 | $7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$90.92M derived: sum of 2 quarters · filed 2016-11-07 | -$91.28M 10-Q · filed 2016-11-07 | -$92.08M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$98.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$98.46M 10-Q · filed 2016-08-08 | -$99.26M derived: sum of 3 quarters · filed 2017-03-01 | -$100.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$363.00K 10-Q · filed 2016-05-09 | -$1.16M derived: sum of 2 quarters · filed 2017-03-01 | -$2.71M derived: sum of 3 quarters · filed 2017-03-01 | -$5.77M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$2.34M derived: sum of 2 quarters · filed 2017-03-01 | -$5.41M derived: sum of 3 quarters · filed 2017-03-01 | -$5.67M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$4.61M derived: sum of 2 quarters · filed 2015-11-09 | -$4.88M 10-Q · filed 2015-11-09 | $34.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$3.33M 10-Q · filed 2015-08-05 | $35.54M derived: sum of 3 quarters · filed 2016-02-29 | $80.83M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$264.00K 10-Q · filed 2015-05-11 | $38.61M derived: sum of 2 quarters · filed 2016-02-29 | $83.90M derived: sum of 3 quarters · filed 2016-02-29 | $30.70M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $38.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $84.17M derived: sum of 2 quarters · filed 2016-02-29 | $30.97M derived: sum of 3 quarters · filed 2016-02-29 | $30.32M 10-K · filed 2016-02-29 |
| 2013-09-30 | $45.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$7.91M derived: sum of 2 quarters · filed 2014-11-07 | -$8.56M 10-Q · filed 2014-11-07 | -$126.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$53.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$53.85M 10-Q · filed 2014-08-11 | -$45.42M derived: sum of 3 quarters · filed 2015-02-27 | -$56.22M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$649.00K 10-Q · filed 2014-05-09 | $7.78M derived: sum of 2 quarters · filed 2015-02-27 | -$3.02M derived: sum of 3 quarters · filed 2015-02-27 | -$7.55M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$2.37M derived: sum of 2 quarters · filed 2015-02-27 | -$6.90M derived: sum of 3 quarters · filed 2015-02-27 | -$24.77M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$15.33M derived: sum of 2 quarters · filed 2013-11-12 | -$33.20M 10-Q · filed 2013-11-12 | $5.94M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$22.40M 10-Q · filed 2013-08-09 | $16.75M derived: sum of 3 quarters · filed 2014-03-03 | $28.84M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$17.87M 10-Q · filed 2013-05-10 | $21.27M derived: sum of 2 quarters · filed 2014-03-03 | $33.37M derived: sum of 3 quarters · filed 2014-03-03 | $37.92M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $39.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $51.24M derived: sum of 2 quarters · filed 2014-03-03 | $55.79M derived: sum of 3 quarters · filed 2014-03-03 | -$14.84M 10-K · filed 2014-03-03 |
| 2011-09-30 | $12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $16.65M derived: sum of 2 quarters · filed 2012-11-09 | -$53.98M 10-Q · filed 2012-11-09 | -$54.81M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $4.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$66.08M 10-Q · filed 2012-08-09 | -$66.91M derived: sum of 3 quarters · filed 2013-03-18 | -$56.91M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$70.63M 10-Q · filed 2012-05-10 | -$71.46M derived: sum of 2 quarters · filed 2013-03-18 | -$61.45M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | -$827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $9.17M derived: sum of 2 quarters · filed 2013-03-18 | -$2.78M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$1.95M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$11.95M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$22.60M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |